Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2020 / Cilt: 25 - Sayı: 3

A Case of SARS-CoV-2 Infection in an HIV Patient

HIV ile İnfekte Olguda SARS-CoV-2 İnfeksiyonu

Pages
453–456
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, it was aimed to evaluate SARS-CoV-2 infection in a patient diagnosed with HIV for six years with negative HIV-1 viral load and a CD4 lymphocyte count of 240 cells/mm3.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus disease 2019, which emerged in Wuhan in China in early December 2019, gradually spread across the world and was declared a pandemic by the World Health Organization on March, 12 2020.
📊
Key Findings & Data:Although data on SARS-CoV-2 infection in HIV-infected cases are still limited, it is thought that the presence of comorbidities is important for mortality and morbidity in infected cases.
💡
Conclusion & Impact:In this report, it was aimed to evaluate SARS-CoV-2 infection in a patient diagnosed with HIV for six years with negative HIV-1 viral load and a CD4 lymphocyte count of 240 cells/mm3.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronavirus disease 2019, which emerged in Wuhan in China in early December 2019, gradually spread across the world and was declared a pandemic by the World Health Organization on March, 12 2020. The disease shows a wide spectrum, ranging from asymptomatic course to severe acute respiratory syndrome. Although data on SARS-CoV-2 infection in HIV-infected cases are still limited, it is thought that the presence of comorbidities is important for mortality and morbidity in infected cases. In this report, it was aimed to evaluate SARS-CoV-2 infection in a patient diagnosed with HIV for six years with negative HIV-1 viral load and a CD4 lymphocyte count of 240 cells/mm3.

Özet

Aralık 2019’un başlarında Çin’in Wuhan şehrinde ortaya çıkan "Koronavirüs hastalığı 2019" giderek dünyaya yayılmış ve Dünya SağlıkÖrgütü tarafından 12 Mart 2020’de salgın olarak ilan edilmiştir. Hastalık asemptomatik seyirden akut ciddi solunum yetersizliğinevaran oldukça geniş bir spektrum göstermektedir. HIV ile infekte olgularda SARS-CoV-2 infeksiyonu ile ilgili veriler henüz sınırlı sayıdaolmakla birlikte komorbiditelerin varlığının infekte olgularda mortalite ve morbidite açısından önem taşıdığı düşünülmektedir. Bu yazıdakliniğimizde altı yıldır HIV tanısı ile takipli HIV-1 viral yükü negatif, CD4 lenfosit sayısı 240 hücre/mm3 olan bir olguda gelişen SARSCoV-2 infeksiyonunun değerlendirilmesi amaçlanmıştır.

🔖

Cite This Article

ERDEM, H. A., KENANOĞLU, O. B., AKYOL, İ., SERTÖZ, R., IŞIKGÖZ, M. T., PULLUKÇU, H. (2020). A Case of SARS-CoV-2 Infection in an HIV Patient. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 25 - Sayı: 3, 453–456. https://ajindex.com/articles/348073

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708-20
  2. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19)- China, 2020. China CDC Weekly 2020;2:113-22 3. Tunçel Kuman Ö, Pullukçu H, Erdem H.A, Kurtaran B, Taşbakan S.E, Taşbakan M. COVID-19 related anxiety in people living with HIV: An online cross-sectional study. Turk J Med Sci 2020 Aug 11. Online ahead of print
  3. Chu CM, Cheng VC, Hung IF, Wong ML, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59:252-6
  4. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 2020;382:1787-99
  5. Zhu F, Cao Y, Xu S, Zhou M. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. J Med Virol 2020;92:529-30
  6. Blanco JL, Ambrosioni J, Garcia F. SARS-COV-2 in patients with HIV: clinical case series. Lancet HIV 2020;7:314-6
  7. Haerter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020;48:681-6
  8. Aydin Altuntaş Ö, Karaosmanoglu Kumbasar H, Yasar Kart K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol 2020;1-3
  9. Petersen E, Gökengin AD. SARS-CoV-2 epidemiology and control, different scenarios for Turkey. Turk J Med Sci 2020;50:509-14.